| Product NDC: | 0065-0654 |
| Proprietary Name: | CILOXAN |
| Non Proprietary Name: | ciprofloxacin hydrochloride |
| Active Ingredient(s): | 3.33 mg/g & nbsp; ciprofloxacin hydrochloride |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0065-0654 |
| Labeler Name: | Alcon Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020369 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980602 |
| Package NDC: | 0065-0654-35 |
| Package Description: | 3.5 g in 1 TUBE (0065-0654-35) |
| NDC Code | 0065-0654-35 |
| Proprietary Name | CILOXAN |
| Package Description | 3.5 g in 1 TUBE (0065-0654-35) |
| Product NDC | 0065-0654 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ciprofloxacin hydrochloride |
| Dosage Form Name | OINTMENT |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19980602 |
| Marketing Category Name | NDA |
| Labeler Name | Alcon Laboratories, Inc. |
| Substance Name | CIPROFLOXACIN HYDROCHLORIDE |
| Strength Number | 3.33 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |